kyoto.jpeg

kyoto

kyotovisitorshost.jpeg

kyotovisitorshost

General information

Announcements(0)

Overview

Pre-registration

Abstract Submission (Oral/Poster Presentation)

Guidelines for Writing Abstracts (Oral/Poster Pres

Program

Sessions

Search presentations

pharm140_e.png

icon_20251203154432448.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts. If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts. We will reply after confirming that you were a participant. Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Timetable

Future vision of the domestic pharmaceutical industry in Japan from the viewpoint of directions of the drug pricing system and cost-effectiveness evaluation.

In recent times, many Japanese industries are not able to overcome the effects of the recession (for example, car manufacturers, electronic device companies, etc.). However, pharmaceutical industries have been able to maintain their financial interests even after the Lehman-shock years. Japan is one of the countries in the word that has much potential for developing new, useful drugs. However, the number of well-known "Made in Japan" drugs known globally and sold abroad is very small. One reason for such a weakness in the Japanese pharmaceutical industry is the specificity of characteristics comprising the pharmaceutical market in Japan with regard to other counties, particularly the US. Since pharmaceutical industries in Japan depend primarily on domestic sales, they focus on domestic needs for drug development. The theme of this symposium is how to continuously develop globally acceptable "Made in Japan" drugs. Four speakers, with different specialties, discuss how drug development can be promoted in Japan. This is an important opportunity for discussing the business side of pharmaceutics at the Pharmaceutical Society of Japan meeting.

How to continuously develop globally acceptable "Made in Japan" drugs?

The 140th Annual Meeting of the Pharmaceutical Society of Japan (Kyoto)

Presentation Information

[S13-4]Future vision of the domestic pharmaceutical industry in Japan from the viewpoint of directions of the drug pricing system and cost-effectiveness evaluation.

Password required to view